Project

BRaIn grant awards for our PhD student and collaborators!

We are excited to announce that our PhD student, Jędrzej Chrzanowski, MD, has secured funding in the 2nd edition of the BRaIn internal grants program. His research project, EPIDIABMap – Comprehensive Dynamic Epigenetic Map of Type 1 Diabetes Management, will investigate chromatin accessibility in PBMCs during the first years after diabetes diagnosis using the ATAC-seq […]

New PhD student in Our Department!

We are pleased to announce that MSc Katarzyna Płoszka has begun her doctoral studies at the newly established Doctoral School of Molecular Medicine at the Medical University of Łódź, which is an initiative of several leading scientific institutions in Poland, focused on molecular research in medicine. Under the supervision of Prof. Wojciech Fendler, MD, PhD, […]

Our PhD student at ISPAD Science School for Physicians!

Worldwide collaboration is the foundation of modern scientific research. This is especially true in the field of pediatric diabetes, which is steadily increasing in prevalence across many countries in Europe and around the world. From September 22 to 27, the International Society for Pediatric and Adolescent Diabetes (ISPAD) organized the ISPAD Science School for Physicians […]

Damian Mikulski awarded Walczak NAWA scholarship for visit at MD Anderson Cancer Centre!

We are pleased to announce that Damian Mikulski, a member of our Department, is among the 40 recipients of research scholarships awarded in the 4th edition of the Walczak NAWA program. Starting in February 2025, Dr. Mikulski will spend five months working with Professor Robert Orlowski, M.D., Ph.D., at the University of Texas MD Anderson […]

Our student, Grzegorz Mirocha, receives UMed Grant 2024!

We are pleased to announce that Grzegorz Mirocha, a student from the Department of Biostatistics and Translational Medicine, has received funding of PLN 30,000 under the “UMed grants” program for his project “Exploring NRP2 and MDK as serum markers for predicting poor mobilization in multiple myeloma patients treated with anti-CD38 monoclonal antibody-based induction therapy”. The […]

We’ve received 2 START scholarships!

On May 10, 2024, two of our scientists, Zuzanna Nowicka, M.D., and Arkadiusz Michalak, M.D., received START scholarships. The START program of the Foundation for Polish Science is the largest scholarship program in Poland for the best young scientists representing all fields of science. Its purpose is to support outstanding young scientists and encourage them […]

“Radonek-AI – a virtual patient assistant for oncological patients” got funding!

We are pleased to inform you that the project ‘Radonek-AI – virtual assistant for oncological patients’ has been granted 70,000.00 PLN as part of the ‘Student Scientific Associations Creating Innovations’ initiative. The project will be carried out by members of the Student Scientific Association of Artificial Intelligence in Oncology, operating at the Department of Biostatistics […]

Dr Konrad Stawiski leading a project within an international consortium!

We are happy to announce that the miRPOC project (“miRPOC: miRNA as biomarkers in early detection and personalised treatment in ovarian cancer”) has been awarded funding under the ERA PerMed Joint Translational Call 2022, co-financed by the European Commission. This project is conducted within an international research consortium and aims to develop and validate a […]

Dr. Ewelina Perdas has been awarded the Bekker NAWA Program scholarship!

We are pleased to announce that Ewelina Perdas, PhD, from our Department, has become one of the 114 laureates of the Bekker NAWA Program – Mieczysław Bekker Program! For one year, starting from May 2024, Dr. Perdas will collaborate with Prof. Theresa L. Whiteside at the UPMC Hillman Cancer Center at the University of Pittsburgh […]

Predictive Potential of Circulating MicroRNA Biomarkers in Patients with High Familial or Genetic Risk of Cancer

In Poland, breast cancer poses an alarming health issue, affecting nearly 20,000 women annually. It is the second most common cause of cancer-related deaths, surpassed only by lung cancer. Ovarian cancer, although less common, is characterized by a very high mortality rate – 2,700 cases per year. One of the key factors increasing the risk […]

Scroll to top